MEIP fundamentals
An in-depth look to MEI Pharma, Inc. operating, investing, and financing activities
MEIP free cash flow for Q4 24 is -18.21 M USD. For 2024, MEIP free cash flow was -50.69 M USD and operating cash flow was -50.68 M USD.
Q2 '23
Q3 '23
Q4 '23
Q1 '24
Q2 '24
Q3 '24
Q4 '24
0.00
Cash from operating activities
Cash from investing activities
Cash from financing activities
Currency: USD
Q2 '23
Q3 '23
Q4 '23
Q1 '24
Q2 '24
Q3 '24
Q4 '24
TTM